SMITHKLINE BEECHAM's ENGERIX-B NEW DOSING SCHEDULE GETS GO- AHEAD FROM FDA CMTE.; AAP/ACIP FLEXIBLE DOSE RECOMMENDATIONS OKAYED FOR ALL HBV VACCINES
Executive Summary
SmithKline Beecham's proposed new dosing schedule for its recombinant hepatitis B vaccine Engerix-B was recommended for approval by FDA's Vaccines & Related Biologicals Advisory Committee at its Jan. 28 meeting.